Hochschulschrift
Cellular function and toxicity of the Parkinson’s disease-related genes α-synuclein and catp-6 in C. elegans
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Göttingen, Georg-August Universität, Diss., 2012
- Keyword
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Göttingen
- (who)
-
Niedersächsische Staats- und Universitätsbibliothek Göttingen
- (when)
-
2013
- Creator
-
Wender, Nora
- Contributor
-
Eimer, Stefan
Jahn, Reinhard
- Handle
-
11858/00-1735-0000-0015-97E4-A
- URN
-
urn:nbn:de:gbv:7-11858/00-1735-0000-0015-97E4-A-6
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Wender, Nora
- Eimer, Stefan
- Jahn, Reinhard
- Niedersächsische Staats- und Universitätsbibliothek Göttingen
Time of origin
- 2013
Other Objects (12)
Analysis of the mechanisms of interaction of alpha-synuclein and membranes in cellular models of Parkinson´s Disease
Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in mice
Models of α-synuclein aggregation in Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Analysis of the mechanisms of interaction of alpha-synuclein and membranes in cellular models of Parkinson´s Disease
Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in mice
Models of α-synuclein aggregation in Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Analysis of the mechanisms of interaction of alpha-synuclein and membranes in cellular models of Parkinson´s Disease
Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in mice
Models of α-synuclein aggregation in Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models